50 studies found for:    " September 02, 2009":" October 02, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Effectiveness of Inpatient Voluntary Counseling and Testing (VCT) in Uganda
Condition: HIV
Interventions: Behavioral: Inpatient HIV testing;   Behavioral: Outpatient HIV testing
22 Completed The St. Marys and The Mater Switch Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
23 Completed HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
Condition: HIV Infections
24 Completed HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs;   Drug: NVP or EFV + 2 NRTIs
25 Unknown  Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Intervention: Drug: maraviroc (Selzentry)
26 Completed Trial Embedded in an Electronic Personal Medical Health Records
Conditions: HIV Infections;   Health Literacy
Interventions: Other: Online access to a personal health record;   Other: No access to the PHR
27 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa
Condition: HIV Infections
Interventions: Drug: FTC/TDF;   Drug: Placebo
28 Completed Pharmacokinetics of Lamivudine at Two Different Doses
Condition: HIV Infections
Intervention: Drug: Lamivudine (3TC)
29 Completed Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: mefloquine
30 Completed
Has Results
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Condition: HIV Infection
Interventions: Biological: DNA + HIV-rAd5 vaccine;   Drug: ART intensification (raltegravir);   Drug: ART intensification (maraviroc)
31 Terminated
Has Results
Effect of Rosuvastatin on Endothelial Function
Conditions: HIV Infections;   Cardiovascular Disease
Intervention: Drug: rosuvastatin
32 Completed Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and Acceptability
Conditions: HIV Infections;   Circumcision
Interventions: Procedure: Circumcision;   Device: Mogen Clamp;   Device: Plastibell;   Device: AccuCirc
33 Completed Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Conditions: HIV Infections;   Lipoatrophy
Interventions: Drug: EFV;   Drug: LPV/r
34 Completed Mothers Living With HIV and Their Adolescent Children
Conditions: Family Relations;   Mental Health;   Physical Health;   Risky Sexual Behavior;   Substance Use;   HIV Infections
Intervention: Behavioral: Cognitive-behavioral, small-group format sessions
35 Completed Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   HIV Infections
Intervention: Other: Early antiretroviral therapy
36 Completed
Has Results
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
Conditions: HIV Infections;   Dyslipidemia;   Endothelial Dysfunction
Intervention: Drug: extended release niacin
37 Completed Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose
Conditions: Immunologic Tests;   HIV Infections
Interventions: Biological: GSK Biologicals' HIV vaccine (732461);   Drug: Chloroquine
38 Completed Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers
Conditions: Tuberculosis;   HIV
Interventions: Drug: Efavirenz (EFV);   Drug: TMC207
39 Completed Telephone Support to Improve Adherence to Anti-HIV Medications
Condition: HIV Infections
Interventions: Behavioral: Enhanced nursing telephone support;   Behavioral: Standard care
40 Completed
Has Results
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: telaprevir or matching placebo;   Biological: peginterferon alfa-2a;   Drug: ribavirin (fixed dose);   Drug: ribavirin (weight-based dose)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Indicates status has not been verified in more than two years